ENDRA Life Sciences Inc. (NDRA)

CIK 1681682 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ENDRA Life Sciences Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20264250001477932-26-006711
Oct 26, 20264250001477932-26-006456
Oct 8, 202630001477932-26-006129
Oct 8, 2026SCHEDULE 13D0001477932-26-006128
Oct 2, 2026S-40001193125-26-410883
Oct 1, 20268-K0001213900-26-105899
Oct 1, 20264250001213900-26-105909
Sep 25, 20264250001213900-26-103599
Sep 14, 20264250001213900-26-099784
Sep 9, 20264250001477932-26-005472
Sep 9, 20264250001477932-26-005473
Aug 21, 20264250001477932-26-005199
Aug 20, 20264250001193125-26-358082
Aug 17, 20268-K0001213900-26-090747
Aug 17, 20264250001213900-26-090755
Aug 14, 202610-Q0001213900-26-090027
Aug 6, 20264250001193125-26-336866
Aug 5, 20264250001193125-26-335463
Aug 4, 20264250001193125-26-333141
Jul 22, 20264250001477932-26-004434
Jul 22, 20264250001477932-26-004439
Jul 17, 20264250001213900-26-078913
Jul 17, 20264250001477932-26-004369
Jul 9, 20268-K0001213900-26-076526
Jun 29, 2026SCHEDULE 13D/A0001213900-26-073318